This phenomenon was also observed in KEYNOTE-407, which may indicate that tTMB was not significantly associated with the effectiveness of pembrolizumab combined with platinum-based chemotherapy or chemotherapy alone as 1L therapy for metastatic NSCLC, regardless of histology [62]. This evidence concerns the gene TMEM200B and non-small cell lung carcinoma.